Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs iShares US Aerospace & Defense ETF (ITA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs iShares US Aerospace & Defense ETF — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while iShares US Aerospace & Defense ETF trades at $206.55 (market cap $11.87B). The key difference: Halozyme Therapeutics Inc. Common Stock and iShares US Aerospace & Defense ETF are close in size by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares US Aerospace & Defense ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and iShares US Aerospace & Defense ETF for 19 Days on average.
| HALO | ITA | |
|---|---|---|
Market Cap | $12.58B | $11.87B |
Volume | 2,179,278 | 1,060,125 |
Sector | Health | Sector/Thematic |
52-Week High | $115.22 | $253.22 |
52-Week Low | $61.63 | $198.23 |
Typical Hold Time | 1 Days | 19 Days |
Enterprise Value | $14.49B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About iShares US Aerospace & Defense ETF
iShares U.S. Aerospace & Defense ETF seeks to track U.S. companies in the aerospace and defense sector. Its holdings include manufacturers of commercial and military aircraft, defense systems, and related equipment.
Read more on ITA →
